Seltoplasmid promotes ulcer healing versus placebo for treating patients with chronic limb-threatening ischemia: HOPE CLTI-2 trial.
Di X, Liu C, Sun S, Qin J, Guo X, Chen Y, Li X, Zhang H, Liu M, Yang L, Zhao H, Lu S, Huang J, Zhang Y, Li J, Lin X, Yao K, Tang J, Wang J, Gao Z, Wang J, Huang X, Xu S, Liu Y, Han W, Ni L, Ye W, Zheng Y, Chen Y, Liu B.
Di X, et al. Among authors: li j, li x.
Mol Ther. 2025 Jul 2;33(7):3423-3433. doi: 10.1016/j.ymthe.2025.04.009. Epub 2025 Apr 11.
Mol Ther. 2025.
PMID: 40221835
Free article.
Clinical Trial.